Sexually Transmitted Diseases

>

Latest News

Gilead Expands Global Access to Lenacapavir With New HIV Prevention Partnership
Gilead Expands Global Access to Lenacapavir With New HIV Prevention Partnership

July 10th 2025

Gilead Sciences has partnered with the Global Fund to supply up to 2 million doses of its long-acting HIV prevention drug, lenacapavir, to low and lower-middle income countries.

FDA Accepts New Drug Application for Merck’s HIV Treatment, Doravirine/Islatravir
FDA Accepts New Drug Application for Merck’s HIV Treatment, Doravirine/Islatravir

July 10th 2025

US Businesses Are Here to Help the Trump Administration Keep its Pledge to End HIV
US Businesses Are Here to Help the Trump Administration Keep its Pledge to End HIV

May 9th 2025

HIV's Golden Age: Responding to the Needs of an Aging Population
HIV's Golden Age: Responding to the Needs of an Aging Population

May 1st 2025

Video Series
Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.